The PE Ratio as of December 2024 (TTM) for United Therapeutics Corporation (UTHR) is 15.98

According to United Therapeutics Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 15.98. This represents a change of 38.03% compared to the average of 11.58 of the last 4 quarters.

United Therapeutics Corporation (UTHR) Historical PE Ratio (quarterly & annually)

How has UTHR PE Ratio performed in the past?

The mean historical PE Ratio of United Therapeutics Corporation over the last ten years is 8.62. The current 15.98 PE Ratio has changed 18.44% with respect to the historical average. Over the past ten years (40 quarters), UTHR's PE Ratio was at its highest in in the December 2017 quarter at 84.10. The PE Ratio was at its lowest in in the March 2015 quarter at -119.45.

United Therapeutics Corporation (UTHR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of United Therapeutics Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

United Therapeutics Corporation (UTHR) Average PE Ratio

How has UTHR PE Ratio performed in the past?

The current PE Ratio of United Therapeutics Corporation (UTHR) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

United Therapeutics Corporation (UTHR) PE Ratio vs. Peers

How is UTHR’s PE Ratio compared to its peers?

United Therapeutics Corporation’s PE Ratio is less than Incyte Corporation (414.17), greater than Alnylam Pharmaceuticals, Inc. (-93.76), greater than Ultragenyx Pharmaceutical Inc. (-7.49), greater than Apellis Pharmaceuticals, Inc. (-16.45), greater than Replimune Group, Inc. (-4.55), greater than Nuvalent, Inc. (-24.55), greater than Ventyx Biosciences, Inc. (-1.09), greater than Ascendis Pharma A/S (-17.94), less than MannKind Corporation (89.51), greater than Larimar Therapeutics, Inc. (-3.90), greater than Day One Biopharmaceuticals, Inc. (-14.55), greater than Kiniksa Pharmaceuticals, Ltd. (-160.17), greater than BeiGene, Ltd. (-21.87), greater than Akero Therapeutics, Inc. (-8.30), greater than Blueprint Medicines Corporation (-44.71), greater than Vaxcyte, Inc. (-21.22), greater than Legend Biotech Corporation (-17.76),

Build a custom stock screener for United Therapeutics Corporation (UTHR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like United Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

United Therapeutics Corporation (UTHR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like United Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.